Toby Steele, MD
Otolaryngology · Sacramento, CANPI 1922236959
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $3,150 of the $5,037 with a category attached, or 62.5%. Intersect ENT, Inc. accounts for 78.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $4,107 and has fallen 94.4% since, to $231 in 2025.
Across 23 payments — averaging $219.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$4K
- Johnson & Johnson$186
- Stryker$179
- Olympus America Inc.$135
- Optinose US, Inc.$135
- AstraZeneca$134
- plus $319 from 3 others
Across 36 payments — averaging $4203.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Optinose US, Inc.$133K
- Stryker$18K
What the payments were for
- Speaking & faculty fees$3,15063%
- Travel & lodging$3146%
- Food & beverage$1,57331%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 10 | $3,949 |
| Johnson & Johnson | 3 | $186 |
| Stryker | 2 | $179 |
| Olympus America Inc. | 1 | $135 |
| Optinose US, Inc. | 1 | $135 |
| AstraZeneca | 1 | $134 |
| Kls-martin L.p. | 3 | $122 |
| Regeneron Healthcare Solutions, Inc. | 1 | $100 |
| Medtronic | 1 | $98 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DIEGO POWERED DISSECTOR BLADE IRRIGATING, SERRATED 4MM DIAMETER STR$135
- RHINO-LARYNGO VIDEOSCOPE$135
- Xhance$135
- TEZSPIRE$134
- SINUVA$119
- ENTELLUS - XPRESS ENT DILATION SYSTEM$106
How this compares
$5,037 in reported general payments places this provider in the 80th percentile of 1,021 otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XhanceFluticasone Propionate | 52 | $39,001 |
| Ipratropium Bromide | 94 | $5,131 |
| Budesonide | 20 | $2,182 |
| Azelastine Hcl | 63 | $1,987 |
| Doxycycline Hyclate | 38 | $497 |
| Fluticasone Propionate | 37 | $459 |
| Montelukast Sodium | 32 | $457 |
| Azithromycin | 28 | $318 |
| Fluocinonide | 14 | $280 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 30 | $260 |
| Omeprazole | 32 | $174 |
| Prednisone | 35 | $100 |
| Mupirocin | 16 | $100 |
| Ibuprofen | 29 | $87 |
| Famotidine | 21 | $80 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $135 | $39,00152 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,021 otolaryngology providers in California.
Other otolaryngology in Sacramento
- Edward StrongSacramento$82K
- Travis TollefsonSacramento$60K
- Scott McCuskerSacramento$38K
- Brian WeeksSan Diego$924K
- Randall OwRoseville$613K
- Amir MoradiVista$389K
- Keith BlackwellLos Angeles$349K
- Kalpna DurairajSun Valley$348K
- Todd MillerNewport Beach$259K
- Jeffrey SuhLos Angeles$223K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.